How Erez Israeli revived Dr Reddy’s by focusing on costs and non-US markets

Erez Israeli who took over as chief executive officer of DRL in 2019 sharpened its focus on costs and execution. Its recovery holds a lesson or two for major drug firms

from Moneycontrol Business News https://www.moneycontrol.com/news/business/how-erez-israeli-revived-dr-reddy’s-by-focusingcostsnon-us-markets_15270581.html